Journal article
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis
Abstract
BACKGROUND: Cognitive enhancers, including cholinesterase inhibitors and memantine, are used to treat dementia, but their effectiveness for mild cognitive impairment is unclear. We conducted a systematic review to examine the efficacy and safety of cognitive enhancers for mild cognitive impairment.
METHODS: Our eligibility criteria were studies of the effects of donepezil, rivastigmine, galantamine or memantine on mild cognitive impairment …
Authors
Tricco AC; Soobiah C; Berliner S; Ho JM; Ng CH; Ashoor HM; Chen MH; Hemmelgarn B; Straus SE
Journal
Canadian Medical Association Journal, Vol. 185, No. 16, pp. 1393–1401
Publisher
Joule
Publication Date
November 5, 2013
DOI
10.1503/cmaj.130451
ISSN
0820-3946